NetEase fell nearly 4% and will announce results tomorrow

Gelonghui May 22 | NetEase-S (9999.HK) fell nearly 4% to HK$152.3, the second consecutive day of decline

Gelonghui May 22 | NetEase-S (9999.HK) fell nearly 4% to HK$152.3. It was the second consecutive day of decline.
NetEase will announce its results before the U.S. stock market opens on May 23.
The agency predicts that NetEase will achieve revenue of 26.786 billion yuan in the first quarter of 2024, a year-on-year increase of 6.95%; earnings per share will be 12.13 yuan, a year-on-year increase of 17.0%.

Like (0)
Previous May 22, 2024 5:59 pm
Next May 22, 2024 5:59 pm

Related posts

  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Stocks that will see action today May 7, 2024

    GHCL has announced a capital budget of approximately ₹224 crore for the financial year 2024-25, including a Bromine Project of ₹117 crore. The board has also approved a 5.5 mt greenfield soda ash project in Kutch, Gujarat, for ₹4,000 crore.

    US stock market May 7, 2024
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Former Bank of Japan chief economist says interest rates may be raised three times this year

    A former chief economist of the Bank of Japan said that from the perspective of the space to adjust excessively loose policies, the Bank of Japan may raise interest rates up to three times this year, and the next action may be as early as June.

    US stock market May 17, 2024
  • Celestica rose 5.8% pre-market, Q1 results beat expectations, raises full-year guidance

    Gelonghui, April 25 | Elevator company Celestica rose 5.8% to US$46.66 before the market opened. According to the news, the company’s adjusted diluted earnings per share in the first quarter was US$0.86, higher than US$0.47 in the same period last year and higher than analysts’ expectations of US$0.75. In 2024, the company expects adjusted earnings per share of $3.30 on revenue of $9.1 billion, up from previous guidance.

    US stock market April 25, 2024
  • Yihua Shares: Net profit in the first quarter of 2024 was 86.6785 million yuan, a year-on-year increase of 456.11%

    CSI Intelligent Financial Information Yihua Co., Ltd. (002897) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 1.529 billion yuan, a year-on-year increase of 63.18%; net profit attributable to the parent company was 86.6785 million yuan, a year-on-year increase of 456.11%; non-net profit after deducting 81.5985 million yuan, a year-on-year increase of 705.72%; generated from operating activities Net cash flow was 6.909 million yuan, compared with -32.6879 million yuan in the same period last year; during the reporting period, Yihua Shares\’ basic earnings per share was 0.51 yuan, and the weighted average return on net assets was 4.89%.

    US stock market April 25, 2024